世界のソラフェニブトシル酸塩錠市場インサイト・予測（～2027年）

• 英文タイトル：Global Sorafenib Tosylate Tablets Market Insights and Forecast to 2027

• レポートコード：QY2108PAL4040 • 出版社/出版日：QYResearch / 2021年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥725,200 (USD4,900)	▷ お問い合わせ
Multi User	￥1,087,800 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,450,400 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査資料はソラフェニブトシル酸塩錠の世界市場の現状について調査・分析し、2027年までの市場を予測しました。ソラフェニブトシル酸塩錠の世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（60個/箱、120個/箱、その他）、用途別市場規模（病院、オンライン販売、薬局、その他）、主要地域別市場規模（北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ）、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。 ・ソラフェニブトシル酸塩錠の世界市場概要 ・メーカー別の競争状況、市場シェア ・ソラフェニブトシル酸塩錠の種類別市場規模：60個/箱、120個/箱、その他 ・ソラフェニブトシル酸塩錠の用途別市場規模：病院、オンライン販売、薬局、その他 ・北米のソラフェニブトシル酸塩錠市場規模2016-2027：種類別、用途別、国別（アメリカ、カナダ） ・ヨーロッパのソラフェニブトシル酸塩錠市場規模2016-2027：種類別、用途別、国別（ドイツ、フランス、イギリス） ・アジアのソラフェニブトシル酸塩錠市場規模2016-2027：種類別、用途別、国別（日本、中国、インド、韓国） ・中南米のソラフェニブトシル酸塩錠市場規模2016-2027：種類別、用途別、国別（メキシコ、ブラジル） ・中東・アフリカのソラフェニブトシル酸塩錠市場規模2016-2027：種類別、用途別、国別（トルコ、サウジアラビア） ・企業情報：Bayer、Cipla、Beijing Yabao Biological Pharmaceutical Co., Ltd.、Chongqing Yaoyou Pharmaceutical Co., Ltd.、Jiangxi Shanxiang Pharmaceutical Co., Ltd.、CSPC Ouyi Pharmaceutical Co., Ltd. ・ソラフェニブトシル酸塩錠のバリューチェーン・販売チャネル分析 ・ソラフェニブトシル酸塩錠の世界市場動向

Sorafenib tosylate Tablets are used as clinical anticancer agents for the treatment of liver and renal cell carcinoma.

Market Analysis and Insights: Global Sorafenib Tosylate Tablets Market
The global Sorafenib Tosylate Tablets market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.

Global Sorafenib Tosylate Tablets Scope and Segment
Sorafenib Tosylate Tablets market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Sorafenib Tosylate Tablets market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
60 Pieces/Box
120 Pieces/Box
Others

Segment by Application
Hospital
Online Sale
Pharmacy
Others

By Company
Bayer
Cipla
Beijing Yabao Biological Pharmaceutical Co., Ltd.
Chongqing Yaoyou Pharmaceutical Co., Ltd.
Jiangxi Shanxiang Pharmaceutical Co., Ltd.
CSPC Ouyi Pharmaceutical Co., Ltd.

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 Sorafenib Tosylate Tablets Product Introduction
1.2 Market by Type
1.2.1 Global Sorafenib Tosylate Tablets Market Size Growth Rate by Type
1.2.2 60 Pieces/Box
1.2.3 120 Pieces/Box
1.2.4 Others
1.3 Market by Application
1.3.1 Global Sorafenib Tosylate Tablets Market Size Growth Rate by Application
1.3.2 Hospital
1.3.3 Online Sale
1.3.4 Pharmacy
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Sorafenib Tosylate Tablets Sales Estimates and Forecasts 2016-2027
2.2 Global Sorafenib Tosylate Tablets Revenue Estimates and Forecasts 2016-2027
2.3 Global Sorafenib Tosylate Tablets Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Sorafenib Tosylate Tablets Regions by Sales
2.4.1 Global Top Sorafenib Tosylate Tablets Regions by Sales (2016-2021)
2.4.2 Global Top Sorafenib Tosylate Tablets Regions by Sales (2022-2027)
2.5 Global Top Sorafenib Tosylate Tablets Regions by Revenue
2.5.1 Global Top Sorafenib Tosylate Tablets Regions by Revenue (2016-2021)
2.5.2 Global Top Sorafenib Tosylate Tablets Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa

3 Competition by Manufacturers
3.1 Global Sorafenib Tosylate Tablets Sales by Manufacturers
3.1.1 Global Top Sorafenib Tosylate Tablets Manufacturers by Sales (2016-2021)
3.1.2 Global Top Sorafenib Tosylate Tablets Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Sorafenib Tosylate Tablets Sales in 2020
3.2 Global Sorafenib Tosylate Tablets Revenue by Manufacturers
3.2.1 Global Top Sorafenib Tosylate Tablets Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Sorafenib Tosylate Tablets Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Sorafenib Tosylate Tablets Revenue in 2020
3.3 Global Sorafenib Tosylate Tablets Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Sorafenib Tosylate Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Sorafenib Tosylate Tablets Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Sorafenib Tosylate Tablets Sales by Type
4.1.1 Global Sorafenib Tosylate Tablets Historical Sales by Type (2016-2021)
4.1.2 Global Sorafenib Tosylate Tablets Forecasted Sales by Type (2022-2027)
4.1.3 Global Sorafenib Tosylate Tablets Sales Market Share by Type (2016-2027)
4.2 Global Sorafenib Tosylate Tablets Revenue by Type
4.2.1 Global Sorafenib Tosylate Tablets Historical Revenue by Type (2016-2021)
4.2.2 Global Sorafenib Tosylate Tablets Forecasted Revenue by Type (2022-2027)
4.2.3 Global Sorafenib Tosylate Tablets Revenue Market Share by Type (2016-2027)
4.3 Global Sorafenib Tosylate Tablets Price by Type
4.3.1 Global Sorafenib Tosylate Tablets Price by Type (2016-2021)
4.3.2 Global Sorafenib Tosylate Tablets Price Forecast by Type (2022-2027)

5 Market Size by Application
5.1 Global Sorafenib Tosylate Tablets Sales by Application
5.1.1 Global Sorafenib Tosylate Tablets Historical Sales by Application (2016-2021)
5.1.2 Global Sorafenib Tosylate Tablets Forecasted Sales by Application (2022-2027)
5.1.3 Global Sorafenib Tosylate Tablets Sales Market Share by Application (2016-2027)
5.2 Global Sorafenib Tosylate Tablets Revenue by Application
5.2.1 Global Sorafenib Tosylate Tablets Historical Revenue by Application (2016-2021)
5.2.2 Global Sorafenib Tosylate Tablets Forecasted Revenue by Application (2022-2027)
5.2.3 Global Sorafenib Tosylate Tablets Revenue Market Share by Application (2016-2027)
5.3 Global Sorafenib Tosylate Tablets Price by Application
5.3.1 Global Sorafenib Tosylate Tablets Price by Application (2016-2021)
5.3.2 Global Sorafenib Tosylate Tablets Price Forecast by Application (2022-2027)

6 North America
6.1 North America Sorafenib Tosylate Tablets Market Size by Type
6.1.1 North America Sorafenib Tosylate Tablets Sales by Type (2016-2027)
6.1.2 North America Sorafenib Tosylate Tablets Revenue by Type (2016-2027)
6.2 North America Sorafenib Tosylate Tablets Market Size by Application
6.2.1 North America Sorafenib Tosylate Tablets Sales by Application (2016-2027)
6.2.2 North America Sorafenib Tosylate Tablets Revenue by Application (2016-2027)
6.3 North America Sorafenib Tosylate Tablets Market Size by Country
6.3.1 North America Sorafenib Tosylate Tablets Sales by Country (2016-2027)
6.3.2 North America Sorafenib Tosylate Tablets Revenue by Country (2016-2027)
6.3.3 United States
6.3.4 Canada

7 Europe
7.1 Europe Sorafenib Tosylate Tablets Market Size by Type
7.1.1 Europe Sorafenib Tosylate Tablets Sales by Type (2016-2027)
7.1.2 Europe Sorafenib Tosylate Tablets Revenue by Type (2016-2027)
7.2 Europe Sorafenib Tosylate Tablets Market Size by Application
7.2.1 Europe Sorafenib Tosylate Tablets Sales by Application (2016-2027)
7.2.2 Europe Sorafenib Tosylate Tablets Revenue by Application (2016-2027)
7.3 Europe Sorafenib Tosylate Tablets Market Size by Country
7.3.1 Europe Sorafenib Tosylate Tablets Sales by Country (2016-2027)
7.3.2 Europe Sorafenib Tosylate Tablets Revenue by Country (2016-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia

8 Asia Pacific
8.1 Asia Pacific Sorafenib Tosylate Tablets Market Size by Type
8.1.1 Asia Pacific Sorafenib Tosylate Tablets Sales by Type (2016-2027)
8.1.2 Asia Pacific Sorafenib Tosylate Tablets Revenue by Type (2016-2027)
8.2 Asia Pacific Sorafenib Tosylate Tablets Market Size by Application
8.2.1 Asia Pacific Sorafenib Tosylate Tablets Sales by Application (2016-2027)
8.2.2 Asia Pacific Sorafenib Tosylate Tablets Revenue by Application (2016-2027)
8.3 Asia Pacific Sorafenib Tosylate Tablets Market Size by Region
8.3.1 Asia Pacific Sorafenib Tosylate Tablets Sales by Region (2016-2027)
8.3.2 Asia Pacific Sorafenib Tosylate Tablets Revenue by Region (2016-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia

9 Latin America
9.1 Latin America Sorafenib Tosylate Tablets Market Size by Type
9.1.1 Latin America Sorafenib Tosylate Tablets Sales by Type (2016-2027)
9.1.2 Latin America Sorafenib Tosylate Tablets Revenue by Type (2016-2027)
9.2 Latin America Sorafenib Tosylate Tablets Market Size by Application
9.2.1 Latin America Sorafenib Tosylate Tablets Sales by Application (2016-2027)
9.2.2 Latin America Sorafenib Tosylate Tablets Revenue by Application (2016-2027)
9.3 Latin America Sorafenib Tosylate Tablets Market Size by Country
9.3.1 Latin America Sorafenib Tosylate Tablets Sales by Country (2016-2027)
9.3.2 Latin America Sorafenib Tosylate Tablets Revenue by Country (2016-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Sorafenib Tosylate Tablets Market Size by Type
10.1.1 Middle East and Africa Sorafenib Tosylate Tablets Sales by Type (2016-2027)
10.1.2 Middle East and Africa Sorafenib Tosylate Tablets Revenue by Type (2016-2027)
10.2 Middle East and Africa Sorafenib Tosylate Tablets Market Size by Application
10.2.1 Middle East and Africa Sorafenib Tosylate Tablets Sales by Application (2016-2027)
10.2.2 Middle East and Africa Sorafenib Tosylate Tablets Revenue by Application (2016-2027)
10.3 Middle East and Africa Sorafenib Tosylate Tablets Market Size by Country
10.3.1 Middle East and Africa Sorafenib Tosylate Tablets Sales by Country (2016-2027)
10.3.2 Middle East and Africa Sorafenib Tosylate Tablets Revenue by Country (2016-2027)
10.3.3 Turkey
10.3.4 Saudi Arabia

11 Company Profiles
11.1 Bayer
11.1.1 Bayer Corporation Information
11.1.2 Bayer Overview
11.1.3 Bayer Sorafenib Tosylate Tablets Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Bayer Sorafenib Tosylate Tablets Product Description
11.1.5 Bayer Recent Developments
11.2 Cipla
11.2.1 Cipla Corporation Information
11.2.2 Cipla Overview
11.2.3 Cipla Sorafenib Tosylate Tablets Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Cipla Sorafenib Tosylate Tablets Product Description
11.2.5 Cipla Recent Developments
11.3 Beijing Yabao Biological Pharmaceutical Co., Ltd.
11.3.1 Beijing Yabao Biological Pharmaceutical Co., Ltd. Corporation Information
11.3.2 Beijing Yabao Biological Pharmaceutical Co., Ltd. Overview
11.3.3 Beijing Yabao Biological Pharmaceutical Co., Ltd. Sorafenib Tosylate Tablets Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Beijing Yabao Biological Pharmaceutical Co., Ltd. Sorafenib Tosylate Tablets Product Description
11.3.5 Beijing Yabao Biological Pharmaceutical Co., Ltd. Recent Developments
11.4 Chongqing Yaoyou Pharmaceutical Co., Ltd.
11.4.1 Chongqing Yaoyou Pharmaceutical Co., Ltd. Corporation Information
11.4.2 Chongqing Yaoyou Pharmaceutical Co., Ltd. Overview
11.4.3 Chongqing Yaoyou Pharmaceutical Co., Ltd. Sorafenib Tosylate Tablets Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Chongqing Yaoyou Pharmaceutical Co., Ltd. Sorafenib Tosylate Tablets Product Description
11.4.5 Chongqing Yaoyou Pharmaceutical Co., Ltd. Recent Developments
11.5 Jiangxi Shanxiang Pharmaceutical Co., Ltd.
11.5.1 Jiangxi Shanxiang Pharmaceutical Co., Ltd. Corporation Information
11.5.2 Jiangxi Shanxiang Pharmaceutical Co., Ltd. Overview
11.5.3 Jiangxi Shanxiang Pharmaceutical Co., Ltd. Sorafenib Tosylate Tablets Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Jiangxi Shanxiang Pharmaceutical Co., Ltd. Sorafenib Tosylate Tablets Product Description
11.5.5 Jiangxi Shanxiang Pharmaceutical Co., Ltd. Recent Developments
11.6 CSPC Ouyi Pharmaceutical Co., Ltd.
11.6.1 CSPC Ouyi Pharmaceutical Co., Ltd. Corporation Information
11.6.2 CSPC Ouyi Pharmaceutical Co., Ltd. Overview
11.6.3 CSPC Ouyi Pharmaceutical Co., Ltd. Sorafenib Tosylate Tablets Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 CSPC Ouyi Pharmaceutical Co., Ltd. Sorafenib Tosylate Tablets Product Description
11.6.5 CSPC Ouyi Pharmaceutical Co., Ltd. Recent Developments

12 Value Chain and Sales Channels Analysis
12.1 Sorafenib Tosylate Tablets Value Chain Analysis
12.2 Sorafenib Tosylate Tablets Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Sorafenib Tosylate Tablets Production Mode & Process
12.4 Sorafenib Tosylate Tablets Sales and Marketing
12.4.1 Sorafenib Tosylate Tablets Sales Channels
12.4.2 Sorafenib Tosylate Tablets Distributors
12.5 Sorafenib Tosylate Tablets Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Sorafenib Tosylate Tablets Industry Trends
13.2 Sorafenib Tosylate Tablets Market Drivers
13.3 Sorafenib Tosylate Tablets Market Challenges
13.4 Sorafenib Tosylate Tablets Market Restraints

14 Key Findings in The Global Sorafenib Tosylate Tablets Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Sorafenib Tosylate Tablets Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of 60 Pieces/Box
Table 3. Major Manufacturers of 120 Pieces/Box
Table 4. Major Manufacturers of Others
Table 5. Global Sorafenib Tosylate Tablets Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 6. Global Sorafenib Tosylate Tablets Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 7. Global Sorafenib Tosylate Tablets Sales by Region (2016-2021) & (K Units)
Table 8. Global Sorafenib Tosylate Tablets Sales Market Share by Region (2016-2021)
Table 9. Global Sorafenib Tosylate Tablets Sales by Region (2022-2027) & (K Units)
Table 10. Global Sorafenib Tosylate Tablets Sales Market Share by Region (2022-2027)
Table 11. Global Sorafenib Tosylate Tablets Revenue by Region (2016-2021) & (US$ Million)
Table 12. Global Sorafenib Tosylate Tablets Revenue Market Share by Region (2016-2021)
Table 13. Global Sorafenib Tosylate Tablets Revenue by Region (2022-2027) & (US$ Million)
Table 14. Global Sorafenib Tosylate Tablets Revenue Market Share by Region (2022-2027)
Table 15. Global Sorafenib Tosylate Tablets Sales by Manufacturers (2016-2021) & (K Units)
Table 16. Global Sorafenib Tosylate Tablets Sales Share by Manufacturers (2016-2021)
Table 17. Global Sorafenib Tosylate Tablets Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 18. Global Sorafenib Tosylate Tablets Revenue Share by Manufacturers (2016-2021)
Table 19. Sorafenib Tosylate Tablets Price by Manufacturers 2016-2021 (US$/Unit)
Table 20. Global Sorafenib Tosylate Tablets Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Sorafenib Tosylate Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sorafenib Tosylate Tablets as of 2020)
Table 22. Sorafenib Tosylate Tablets Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Sorafenib Tosylate Tablets Product Offered
Table 24. Date of Manufacturers Enter into Sorafenib Tosylate Tablets Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Sorafenib Tosylate Tablets Sales by Type (2016-2021) & (K Units)
Table 27. Global Sorafenib Tosylate Tablets Sales by Type (2022-2027) & (K Units)
Table 28. Global Sorafenib Tosylate Tablets Sales Share by Type (2016-2021)
Table 29. Global Sorafenib Tosylate Tablets Sales Share by Type (2022-2027)
Table 30. Global Sorafenib Tosylate Tablets Revenue by Type (2016-2021) & (US$ Million)
Table 31. Global Sorafenib Tosylate Tablets Revenue by Type (2022-2027) & (US$ Million)
Table 32. Global Sorafenib Tosylate Tablets Revenue Share by Type (2016-2021)
Table 33. Global Sorafenib Tosylate Tablets Revenue Share by Type (2022-2027)
Table 34. Sorafenib Tosylate Tablets Price by Type (2016-2021) & (US$/Unit)
Table 35. Global Sorafenib Tosylate Tablets Price Forecast by Type (2022-2027) & (US$/Unit)
Table 36. Global Sorafenib Tosylate Tablets Sales by Application (2016-2021) & (K Units)
Table 37. Global Sorafenib Tosylate Tablets Sales by Application (2022-2027) & (K Units)
Table 38. Global Sorafenib Tosylate Tablets Sales Share by Application (2016-2021)
Table 39. Global Sorafenib Tosylate Tablets Sales Share by Application (2022-2027)
Table 40. Global Sorafenib Tosylate Tablets Revenue by Application (2016-2021) & (US$ Million)
Table 41. Global Sorafenib Tosylate Tablets Revenue by Application (2022-2027) & (US$ Million)
Table 42. Global Sorafenib Tosylate Tablets Revenue Share by Application (2016-2021)
Table 43. Global Sorafenib Tosylate Tablets Revenue Share by Application (2022-2027)
Table 44. Sorafenib Tosylate Tablets Price by Application (2016-2021) & (US$/Unit)
Table 45. Global Sorafenib Tosylate Tablets Price Forecast by Application (2022-2027) & (US$/Unit)
Table 46. North America Sorafenib Tosylate Tablets Sales by Type (2016-2021) & (K Units)
Table 47. North America Sorafenib Tosylate Tablets Sales by Type (2022-2027) & (K Units)
Table 48. North America Sorafenib Tosylate Tablets Revenue by Type (2016-2021) & (US$ Million)
Table 49. North America Sorafenib Tosylate Tablets Revenue by Type (2022-2027) & (US$ Million)
Table 50. North America Sorafenib Tosylate Tablets Sales by Application (2016-2021) & (K Units)
Table 51. North America Sorafenib Tosylate Tablets Sales by Application (2022-2027) & (K Units)
Table 52. North America Sorafenib Tosylate Tablets Revenue by Application (2016-2021) & (US$ Million)
Table 53. North America Sorafenib Tosylate Tablets Revenue by Application (2022-2027) & (US$ Million)
Table 54. North America Sorafenib Tosylate Tablets Sales by Country (2016-2021) & (K Units)
Table 55. North America Sorafenib Tosylate Tablets Sales by Country (2022-2027) & (K Units)
Table 56. North America Sorafenib Tosylate Tablets Revenue by Country (2016-2021) & (US$ Million)
Table 57. North America Sorafenib Tosylate Tablets Revenue by Country (2022-2027) & (US$ Million)
Table 58. Europe Sorafenib Tosylate Tablets Sales by Type (2016-2021) & (K Units)
Table 59. Europe Sorafenib Tosylate Tablets Sales by Type (2022-2027) & (K Units)
Table 60. Europe Sorafenib Tosylate Tablets Revenue by Type (2016-2021) & (US$ Million)
Table 61. Europe Sorafenib Tosylate Tablets Revenue by Type (2022-2027) & (US$ Million)
Table 62. Europe Sorafenib Tosylate Tablets Sales by Application (2016-2021) & (K Units)
Table 63. Europe Sorafenib Tosylate Tablets Sales by Application (2022-2027) & (K Units)
Table 64. Europe Sorafenib Tosylate Tablets Revenue by Application (2016-2021) & (US$ Million)
Table 65. Europe Sorafenib Tosylate Tablets Revenue by Application (2022-2027) & (US$ Million)
Table 66. Europe Sorafenib Tosylate Tablets Sales by Country (2016-2021) & (K Units)
Table 67. Europe Sorafenib Tosylate Tablets Sales by Country (2022-2027) & (K Units)
Table 68. Europe Sorafenib Tosylate Tablets Revenue by Country (2016-2021) & (US$ Million)
Table 69. Europe Sorafenib Tosylate Tablets Revenue by Country (2022-2027) & (US$ Million)
Table 70. Asia Pacific Sorafenib Tosylate Tablets Sales by Type (2016-2021) & (K Units)
Table 71. Asia Pacific Sorafenib Tosylate Tablets Sales by Type (2022-2027) & (K Units)
Table 72. Asia Pacific Sorafenib Tosylate Tablets Revenue by Type (2016-2021) & (US$ Million)
Table 73. Asia Pacific Sorafenib Tosylate Tablets Revenue by Type (2022-2027) & (US$ Million)
Table 74. Asia Pacific Sorafenib Tosylate Tablets Sales by Application (2016-2021) & (K Units)
Table 75. Asia Pacific Sorafenib Tosylate Tablets Sales by Application (2022-2027) & (K Units)
Table 76. Asia Pacific Sorafenib Tosylate Tablets Revenue by Application (2016-2021) & (US$ Million)
Table 77. Asia Pacific Sorafenib Tosylate Tablets Revenue by Application (2022-2027) & (US$ Million)
Table 78. Asia Pacific Sorafenib Tosylate Tablets Sales by Region (2016-2021) & (K Units)
Table 79. Asia Pacific Sorafenib Tosylate Tablets Sales by Region (2022-2027) & (K Units)
Table 80. Asia Pacific Sorafenib Tosylate Tablets Revenue by Region (2016-2021) & (US$ Million)
Table 81. Asia Pacific Sorafenib Tosylate Tablets Revenue by Region (2022-2027) & (US$ Million)
Table 82. Latin America Sorafenib Tosylate Tablets Sales by Type (2016-2021) & (K Units)
Table 83. Latin America Sorafenib Tosylate Tablets Sales by Type (2022-2027) & (K Units)
Table 84. Latin America Sorafenib Tosylate Tablets Revenue by Type (2016-2021) & (US$ Million)
Table 85. Latin America Sorafenib Tosylate Tablets Revenue by Type (2022-2027) & (US$ Million)
Table 86. Latin America Sorafenib Tosylate Tablets Sales by Application (2016-2021) & (K Units)
Table 87. Latin America Sorafenib Tosylate Tablets Sales by Application (2022-2027) & (K Units)
Table 88. Latin America Sorafenib Tosylate Tablets Revenue by Application (2016-2021) & (US$ Million)
Table 89. Latin America Sorafenib Tosylate Tablets Revenue by Application (2022-2027) & (US$ Million)
Table 90. Latin America Sorafenib Tosylate Tablets Sales by Country (2016-2021) & (K Units)
Table 91. Latin America Sorafenib Tosylate Tablets Sales by Country (2022-2027) & (K Units)
Table 92. Latin America Sorafenib Tosylate Tablets Revenue by Country (2016-2021) & (US$ Million)
Table 93. Latin America Sorafenib Tosylate Tablets Revenue by Country (2022-2027) & (US$ Million)
Table 94. Middle East and Africa Sorafenib Tosylate Tablets Sales by Type (2016-2021) & (K Units)
Table 95. Middle East and Africa Sorafenib Tosylate Tablets Sales by Type (2022-2027) & (K Units)
Table 96. Middle East and Africa Sorafenib Tosylate Tablets Revenue by Type (2016-2021) & (US$ Million)
Table 97. Middle East and Africa Sorafenib Tosylate Tablets Revenue by Type (2022-2027) & (US$ Million)
Table 98. Middle East and Africa Sorafenib Tosylate Tablets Sales by Application (2016-2021) & (K Units)
Table 99. Middle East and Africa Sorafenib Tosylate Tablets Sales by Application (2022-2027) & (K Units)
Table 100. Middle East and Africa Sorafenib Tosylate Tablets Revenue by Application (2016-2021) & (US$ Million)
Table 101. Middle East and Africa Sorafenib Tosylate Tablets Revenue by Application (2022-2027) & (US$ Million)
Table 102. Middle East and Africa Sorafenib Tosylate Tablets Sales by Country (2016-2021) & (K Units)
Table 103. Middle East and Africa Sorafenib Tosylate Tablets Sales by Country (2022-2027) & (K Units)
Table 104. Middle East and Africa Sorafenib Tosylate Tablets Revenue by Country (2016-2021) & (US$ Million)
Table 105. Middle East and Africa Sorafenib Tosylate Tablets Revenue by Country (2022-2027) & (US$ Million)
Table 106. Bayer Corporation Information
Table 107. Bayer Description and Major Businesses
Table 108. Bayer Sorafenib Tosylate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 109. Bayer Sorafenib Tosylate Tablets Product
Table 110. Bayer Recent Developments
Table 111. Cipla Corporation Information
Table 112. Cipla Description and Major Businesses
Table 113. Cipla Sorafenib Tosylate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 114. Cipla Sorafenib Tosylate Tablets Product
Table 115. Cipla Recent Developments
Table 116. Beijing Yabao Biological Pharmaceutical Co., Ltd. Corporation Information
Table 117. Beijing Yabao Biological Pharmaceutical Co., Ltd. Description and Major Businesses
Table 118. Beijing Yabao Biological Pharmaceutical Co., Ltd. Sorafenib Tosylate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 119. Beijing Yabao Biological Pharmaceutical Co., Ltd. Sorafenib Tosylate Tablets Product
Table 120. Beijing Yabao Biological Pharmaceutical Co., Ltd. Recent Developments
Table 121. Chongqing Yaoyou Pharmaceutical Co., Ltd. Corporation Information
Table 122. Chongqing Yaoyou Pharmaceutical Co., Ltd. Description and Major Businesses
Table 123. Chongqing Yaoyou Pharmaceutical Co., Ltd. Sorafenib Tosylate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 124. Chongqing Yaoyou Pharmaceutical Co., Ltd. Sorafenib Tosylate Tablets Product
Table 125. Chongqing Yaoyou Pharmaceutical Co., Ltd. Recent Developments
Table 126. Jiangxi Shanxiang Pharmaceutical Co., Ltd. Corporation Information
Table 127. Jiangxi Shanxiang Pharmaceutical Co., Ltd. Description and Major Businesses
Table 128. Jiangxi Shanxiang Pharmaceutical Co., Ltd. Sorafenib Tosylate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 129. Jiangxi Shanxiang Pharmaceutical Co., Ltd. Sorafenib Tosylate Tablets Product
Table 130. Jiangxi Shanxiang Pharmaceutical Co., Ltd. Recent Developments
Table 131. CSPC Ouyi Pharmaceutical Co., Ltd. Corporation Information
Table 132. CSPC Ouyi Pharmaceutical Co., Ltd. Description and Major Businesses
Table 133. CSPC Ouyi Pharmaceutical Co., Ltd. Sorafenib Tosylate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 134. CSPC Ouyi Pharmaceutical Co., Ltd. Sorafenib Tosylate Tablets Product
Table 135. CSPC Ouyi Pharmaceutical Co., Ltd. Recent Developments
Table 136. Key Raw Materials Lists
Table 137. Raw Materials Key Suppliers Lists
Table 138. Sorafenib Tosylate Tablets Distributors List
Table 139. Sorafenib Tosylate Tablets Customers List
Table 140. Sorafenib Tosylate Tablets Market Trends
Table 141. Sorafenib Tosylate Tablets Market Drivers
Table 142. Sorafenib Tosylate Tablets Market Challenges
Table 143. Sorafenib Tosylate Tablets Market Restraints
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Sorafenib Tosylate Tablets Product Picture
Figure 2. Global Sorafenib Tosylate Tablets Market Share by Type in 2020 & 2027
Figure 3. 60 Pieces/Box Product Picture
Figure 4. 120 Pieces/Box Product Picture
Figure 5. Others Product Picture
Figure 6. Global Sorafenib Tosylate Tablets Market Share by Application in 2020 & 2027
Figure 7. Hospital
Figure 8. Online Sale
Figure 9. Pharmacy
Figure 10. Others
Figure 11. Sorafenib Tosylate Tablets Report Years Considered
Figure 12. Global Sorafenib Tosylate Tablets Sales 2016-2027 (K Units)
Figure 13. Global Sorafenib Tosylate Tablets Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Sorafenib Tosylate Tablets Revenue 2016-2027 (US$ Million)
Figure 15. Global Sorafenib Tosylate Tablets Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 16. Global Sorafenib Tosylate Tablets Sales Market Share by Region (2016-2021)
Figure 17. Global Sorafenib Tosylate Tablets Sales Market Share by Region (2022-2027)
Figure 18. North America Sorafenib Tosylate Tablets Sales YoY (2016-2027) & (K Units)
Figure 19. North America Sorafenib Tosylate Tablets Revenue YoY (2016-2027) & (US$ Million)
Figure 20. Europe Sorafenib Tosylate Tablets Sales YoY (2016-2027) & (K Units)
Figure 21. Europe Sorafenib Tosylate Tablets Revenue YoY (2016-2027) & (US$ Million)
Figure 22. Asia-Pacific Sorafenib Tosylate Tablets Sales YoY (2016-2027) & (K Units)
Figure 23. Asia-Pacific Sorafenib Tosylate Tablets Revenue YoY (2016-2027) & (US$ Million)
Figure 24. Latin America Sorafenib Tosylate Tablets Sales YoY (2016-2027) & (K Units)
Figure 25. Latin America Sorafenib Tosylate Tablets Revenue YoY (2016-2027) & (US$ Million)
Figure 26. Middle East & Africa Sorafenib Tosylate Tablets Sales YoY (2016-2027) & (K Units)
Figure 27. Middle East & Africa Sorafenib Tosylate Tablets Revenue YoY (2016-2027) & (US$ Million)
Figure 28. The Top 10 and Top 5 Players Market Share by Sorafenib Tosylate Tablets Sales in 2020
Figure 29. The Top 10 and Top 5 Players Market Share by Sorafenib Tosylate Tablets Revenue in 2020
Figure 30. Sorafenib Tosylate Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 31. Global Sorafenib Tosylate Tablets Sales Market Share by Type (2016-2027)
Figure 32. Global Sorafenib Tosylate Tablets Revenue Market Share by Type (2016-2027)
Figure 33. Global Sorafenib Tosylate Tablets Sales Market Share by Application (2016-2027)
Figure 34. Global Sorafenib Tosylate Tablets Revenue Market Share by Application (2016-2027)
Figure 35. North America Sorafenib Tosylate Tablets Sales Market Share by Type (2016-2027)
Figure 36. North America Sorafenib Tosylate Tablets Revenue Market Share by Type (2016-2027)
Figure 37. North America Sorafenib Tosylate Tablets Sales Market Share by Application (2016-2027)
Figure 38. North America Sorafenib Tosylate Tablets Revenue Market Share by Application (2016-2027)
Figure 39. North America Sorafenib Tosylate Tablets Sales Share by Country (2016-2027)
Figure 40. North America Sorafenib Tosylate Tablets Revenue Share by Country (2016-2027)
Figure 41. United States Sorafenib Tosylate Tablets Revenue (2016-2027) & (US$ Million)
Figure 42. Canada Sorafenib Tosylate Tablets Revenue (2016-2027) & (US$ Million)
Figure 43. Europe Sorafenib Tosylate Tablets Sales Market Share by Type (2016-2027)
Figure 44. Europe Sorafenib Tosylate Tablets Revenue Market Share by Type (2016-2027)
Figure 45. Europe Sorafenib Tosylate Tablets Sales Market Share by Application (2016-2027)
Figure 46. Europe Sorafenib Tosylate Tablets Revenue Market Share by Application (2016-2027)
Figure 47. Europe Sorafenib Tosylate Tablets Sales Share by Country (2016-2027)
Figure 48. Europe Sorafenib Tosylate Tablets Revenue Share by Country (2016-2027)
Figure 49. Germany Sorafenib Tosylate Tablets Revenue (2016-2027) & (US$ Million)
Figure 50. France Sorafenib Tosylate Tablets Revenue (2016-2027) & (US$ Million)
Figure 51. U.K. Sorafenib Tosylate Tablets Revenue (2016-2027) & (US$ Million)
Figure 52. Italy Sorafenib Tosylate Tablets Revenue (2016-2027) & (US$ Million)
Figure 53. Russia Sorafenib Tosylate Tablets Revenue (2016-2027) & (US$ Million)
Figure 54. Asia Pacific Sorafenib Tosylate Tablets Sales Market Share by Type (2016-2027)
Figure 55. Asia Pacific Sorafenib Tosylate Tablets Revenue Market Share by Type (2016-2027)
Figure 56. Asia Pacific Sorafenib Tosylate Tablets Sales Market Share by Application (2016-2027)
Figure 57. Asia Pacific Sorafenib Tosylate Tablets Revenue Market Share by Application (2016-2027)
Figure 58. Asia Pacific Sorafenib Tosylate Tablets Sales Share by Region (2016-2027)
Figure 59. Asia Pacific Sorafenib Tosylate Tablets Revenue Share by Region (2016-2027)
Figure 60. China Sorafenib Tosylate Tablets Revenue (2016-2027) & (US$ Million)
Figure 61. Japan Sorafenib Tosylate Tablets Revenue (2016-2027) & (US$ Million)
Figure 62. South Korea Sorafenib Tosylate Tablets Revenue (2016-2027) & (US$ Million)
Figure 63. India Sorafenib Tosylate Tablets Revenue (2016-2027) & (US$ Million)
Figure 64. Australia Sorafenib Tosylate Tablets Revenue (2016-2027) & (US$ Million)
Figure 65. China Taiwan Sorafenib Tosylate Tablets Revenue (2016-2027) & (US$ Million)
Figure 66. Indonesia Sorafenib Tosylate Tablets Revenue (2016-2027) & (US$ Million)
Figure 67. Thailand Sorafenib Tosylate Tablets Revenue (2016-2027) & (US$ Million)
Figure 68. Malaysia Sorafenib Tosylate Tablets Revenue (2016-2027) & (US$ Million)
Figure 69. Latin America Sorafenib Tosylate Tablets Sales Market Share by Type (2016-2027)
Figure 70. Latin America Sorafenib Tosylate Tablets Revenue Market Share by Type (2016-2027)
Figure 71. Latin America Sorafenib Tosylate Tablets Sales Market Share by Application (2016-2027)
Figure 72. Latin America Sorafenib Tosylate Tablets Revenue Market Share by Application (2016-2027)
Figure 73. Latin America Sorafenib Tosylate Tablets Sales Share by Country (2016-2027)
Figure 74. Latin America Sorafenib Tosylate Tablets Revenue Share by Country (2016-2027)
Figure 75. Mexico Sorafenib Tosylate Tablets Revenue (2016-2027) & (US$ Million)
Figure 76. Brazil Sorafenib Tosylate Tablets Revenue (2016-2027) & (US$ Million)
Figure 77. Argentina Sorafenib Tosylate Tablets Revenue (2016-2027) & (US$ Million)
Figure 78. Middle East and Africa Sorafenib Tosylate Tablets Sales Market Share by Type (2016-2027)
Figure 79. Middle East and Africa Sorafenib Tosylate Tablets Revenue Market Share by Type (2016-2027)
Figure 80. Middle East and Africa Sorafenib Tosylate Tablets Sales Market Share by Application (2016-2027)
Figure 81. Middle East and Africa Sorafenib Tosylate Tablets Revenue Market Share by Application (2016-2027)
Figure 82. Middle East and Africa Sorafenib Tosylate Tablets Sales Share by Country (2016-2027)
Figure 83. Middle East and Africa Sorafenib Tosylate Tablets Revenue Share by Country (2016-2027)
Figure 84. Turkey Sorafenib Tosylate Tablets Revenue (2016-2027) & (US$ Million)
Figure 85. Saudi Arabia Sorafenib Tosylate Tablets Revenue (2016-2027) & (US$ Million)
Figure 86. UAE Sorafenib Tosylate Tablets Revenue (2016-2027) & (US$ Million)
Figure 87. Sorafenib Tosylate Tablets Value Chain
Figure 88. Sorafenib Tosylate Tablets Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed

---